Literature DB >> 30865179

Factors Associated With Excess Myocardial Infarction Risk in HIV-Infected Adults: A Systematic Review and Meta-analysis.

Shreya G Rao1, Karla I Galaviz2, Hawkins C Gay3, Jingkai Wei4, Wendy S Armstrong5, Carlos Del Rio2,6, K M Venkat Narayan2, Mohammed K Ali2.   

Abstract

OBJECTIVES: To estimate the pooled relative risk (RR) of incident acute myocardial infarction (AMI) among HIV-infected adults compared with HIV-uninfected controls and explore the contribution of traditional and HIV-related risk factors.
BACKGROUND: Understanding AMI risk and associated risk factors in HIV-infected populations has the potential to inform clinical management and prevention strategies.
METHODS: We systematically identified cohort studies of HIV-infected or HIV-infected and matched uninfected adults reporting AMI incidence rates published up to January 1, 2017. Random-effects meta-analysis models were used to estimate the aggregate RR of AMI by HIV status. Subgroup analysis and meta-regression were used to explore factors affecting risk.
RESULTS: Sixteen studies (N = 1,619,690, median age 38.5 years, 78.9% male, mean follow-up of 6.5 years) were included. In pooled analyses of HIV-infected and matched uninfected cohorts (n = 5), HIV-infected individuals had higher AMI incidence rates (absolute risk difference = 2.2 cases per 1000 persons per year) and twice the risk of AMI [RR = 1.96 (1.5-2.6)] compared with matched HIV-uninfected controls. In a multivariate meta-regression, each additional percentage point in the proportion of male participants [odds ratio (OR) = 1.20 (1.14-1.27)] and each additional percentage point in the prevalence of hypertension [OR = 1.19 (1.12-1.27)], dyslipidemia [OR = 1.09 (1.07-1.11)], and smoking [OR = 1.09 (1.05-1.13)] were independently associated with increased AMI risk in HIV-infected adults. CONCLUSIONS AND RELEVANCE: Chronic HIV infection is associated with a 2-fold higher AMI risk. Traditional risk factors such as hypertension, dyslipidemia, and smoking are significant contributors to AMI risk among HIV-infected adults and should be aggressively targeted in routine HIV care.

Entities:  

Mesh:

Year:  2019        PMID: 30865179      PMCID: PMC6622459          DOI: 10.1097/QAI.0000000000001996

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  34 in total

1.  Association between HIV infection, antiretroviral therapy, and risk of acute myocardial infarction: a cohort and nested case-control study using Québec's public health insurance database.

Authors:  Madeleine Durand; Odile Sheehy; Jean-Guy Baril; Jacques Lelorier; Cécile L Tremblay
Journal:  J Acquir Immune Defic Syndr       Date:  2011-07-01       Impact factor: 3.731

2.  [GeSIDA/National AIDS Plan: Consensus document on antiretroviral therapy in adults infected by the human immunodeficiency virus (Updated January 2014)].

Authors: 
Journal:  Enferm Infecc Microbiol Clin       Date:  2014-06-19       Impact factor: 1.731

3.  Comparison of the risks of atherosclerotic events versus death from other causes associated with antiretroviral use.

Authors:  Grace P S Kwong; Azra C Ghani; Richard A Rode; Lucy M Bartley; Benjamin J Cowling; Barbara da Silva; Christl A Donnelly; Ard I van Sighem; D William Cameron; Sven A Danner; Frank de Wolf; Roy M Anderson
Journal:  AIDS       Date:  2006-10-03       Impact factor: 4.177

4.  Association of immunologic and virologic factors with myocardial infarction rates in a US healthcare system.

Authors:  Virginia A Triant; Susan Regan; Hang Lee; Paul E Sax; James B Meigs; Steven K Grinspoon
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12-15       Impact factor: 3.731

5.  Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study.

Authors:  Barbara Hasse; Bruno Ledergerber; Hansjakob Furrer; Manuel Battegay; Bernhard Hirschel; Matthias Cavassini; Barbara Bertisch; Enos Bernasconi; Rainer Weber
Journal:  Clin Infect Dis       Date:  2011-10-13       Impact factor: 9.079

6.  HIV infection and the risk of acute myocardial infarction.

Authors:  Matthew S Freiberg; Chung-Chou H Chang; Lewis H Kuller; Melissa Skanderson; Elliott Lowy; Kevin L Kraemer; Adeel A Butt; Matthew Bidwell Goetz; David Leaf; Kris Ann Oursler; David Rimland; Maria Rodriguez Barradas; Sheldon Brown; Cynthia Gibert; Kathy McGinnis; Kristina Crothers; Jason Sico; Heidi Crane; Alberta Warner; Stephen Gottlieb; John Gottdiener; Russell P Tracy; Matthew Budoff; Courtney Watson; Kaku A Armah; Donna Doebler; Kendall Bryant; Amy C Justice
Journal:  JAMA Intern Med       Date:  2013-04-22       Impact factor: 21.873

7.  Comparison of risk and age at diagnosis of myocardial infarction, end-stage renal disease, and non-AIDS-defining cancer in HIV-infected versus uninfected adults.

Authors:  Keri N Althoff; Kathleen A McGinnis; Christina M Wyatt; Matthew S Freiberg; Cynthia Gilbert; Krisann K Oursler; David Rimland; Maria C Rodriguez-Barradas; Robert Dubrow; Lesley S Park; Melissa Skanderson; Meredith S Shiels; Stephen J Gange; Kelly A Gebo; Amy C Justice
Journal:  Clin Infect Dis       Date:  2014-10-30       Impact factor: 9.079

Review 8.  HIV infection as vascular risk: A systematic review of the literature and meta-analysis.

Authors:  Jose Gutierrez; Ana Letícia A Albuquerque; Louise Falzon
Journal:  PLoS One       Date:  2017-05-11       Impact factor: 3.240

9.  Regional differences in AIDS and non-AIDS related mortality in HIV-positive individuals across Europe and Argentina: the EuroSIDA study.

Authors:  Joanne Reekie; Justyna D Kowalska; Igor Karpov; Jurgen Rockstroh; Anders Karlsson; Aza Rakhmanova; Andrzej Horban; Ole Kirk; Jens D Lundgren; Amanda Mocroft
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

Review 10.  Risk of cardiovascular disease from antiretroviral therapy for HIV: a systematic review.

Authors:  Clay Bavinger; Eran Bendavid; Katherine Niehaus; Richard A Olshen; Ingram Olkin; Vandana Sundaram; Nicole Wein; Mark Holodniy; Nanjiang Hou; Douglas K Owens; Manisha Desai
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

View more
  12 in total

1.  Are New Antiretroviral Treatments Increasing the Risk of Weight Gain?

Authors:  Shahini Shah; Laura Hindley; Andrew Hill
Journal:  Drugs       Date:  2021-01-05       Impact factor: 9.546

Review 2.  Contemporary Lifestyle Modification Interventions to Improve Metabolic Comorbidities in HIV.

Authors:  Kathleen V Fitch
Journal:  Curr HIV/AIDS Rep       Date:  2019-12       Impact factor: 5.071

3.  Cardiovascular risk factors and markers of myocardial injury and inflammation in people living with HIV in Nairobi, Kenya: a pilot cross-sectional study.

Authors:  Michael H Chung; Anoop Sv Shah; Hassan Adan Ahmed; Jeilan Mohamed; Isaiah G Akuku; Kuan Ken Lee; Shirjel R Alam; Pablo Perel; Jasmit Shah; Mohammed K Ali; Sherry Eskander
Journal:  BMJ Open       Date:  2022-06-06       Impact factor: 3.006

4.  Fatty Liver Disease in a Prospective North American Cohort of Adults With Human Immunodeficiency Virus and Hepatitis B Virus Coinfection.

Authors:  Mandana Khalili; Wendy C King; David E Kleiner; Mamta K Jain; Raymond T Chung; Mark Sulkowski; Mauricio Lisker-Melman; David K Wong; Marc Ghany; Arun Sanyal; Richard K Sterling
Journal:  Clin Infect Dis       Date:  2021-11-02       Impact factor: 20.999

5.  Weight gain in antiretroviral therapy-naive HIV-1-infected patients starting a regimen including an integrase strand transfer inhibitor or darunavir/ritonavir.

Authors:  Leonardo Calza; Vincenzo Colangeli; Marco Borderi; Isabella Bon; Aurora Borioni; Francesca Volpato; Maria Carla Re; Pierluigi Viale
Journal:  Infection       Date:  2019-11-12       Impact factor: 3.553

6.  Metabolic Changes Associated With the Use of Integrase Strand Transfer Inhibitors Among Virally Controlled Women.

Authors:  Nathan A Summers; Cecile D Lahiri; Christine D Angert; Amalia Aldredge; C Christina Mehta; Ighovwerha Ofotokun; Anne M Kerchberger; Deborah Gustafson; Sheri D Weiser; Seble Kassaye; Deborah Konkle-Parker; Anjali Sharma; Adaora A Adimora; Hector Bolivar; Jennifer Cocohoba; Audrey L French; Elizabeth T Golub; Anandi N Sheth
Journal:  J Acquir Immune Defic Syndr       Date:  2020-11-01       Impact factor: 3.771

Review 7.  Good Fences Make Good Neighbors: Human Immunodeficiency Virus and Vascular Disease.

Authors:  Elizabeth S Mayne; Susan Louw
Journal:  Open Forum Infect Dis       Date:  2019-06-25       Impact factor: 3.835

8.  Epidemiology of multimorbidity among people living with HIV in sub-Saharan Africa: a systematic review protocol.

Authors:  Kelechi Elizabeth Oladimeji; Armstrong Dzomba; Olatunji Adetokunboh; Lindiwe Zungu; Sanni Yaya; Daniel Ter Goon
Journal:  BMJ Open       Date:  2020-12-12       Impact factor: 2.692

9.  The changing patterns of comorbidities associated with human immunodeficiency virus infection, a longitudinal retrospective cohort study of Medicare patients.

Authors:  Nick D Williams; Vojtech Huser; Frank Rhame; Craig S Mayer; Kin Wah Fung
Journal:  Medicine (Baltimore)       Date:  2021-04-23       Impact factor: 1.817

Review 10.  Viral Bad News Sent by EVAIL.

Authors:  Matthias Clauss; Sarvesh Chelvanambi; Christine Cook; Rabab ElMergawy; Navneet Dhillon
Journal:  Viruses       Date:  2021-06-18       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.